Author Question: Stimulus equivalence: a. Means that two stimuli share a number of common features. b. Is ... (Read 48 times)

Garrulous

  • Hero Member
  • *****
  • Posts: 686
Stimulus equivalence:
 
  a. Means that two stimuli share a number of common features.
  b. Is important to the development of stimulus discrimination.
  c. Means that a person responds accurately to untrained and nonreinforced stimulus-stimulus relations following training on different stimulus-stimulus relations.
  d. Requires testing of reflexivity, symmetry, and commonality.

Question 2

Punishment by contingent removal of a stimulus is also known as:
 
  a. Negative reinforcement.
  b. Negative punishment.
  c. Type II punishment.
  d. Positive punishment.
  e. All of the above.
  f. A,B,C only.
  g. B and C only.



Kimmy

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

C

Answer to Question 2

G



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Human kidneys will clean about 1 million gallons of blood in an average lifetime.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Multiple sclerosis is a condition wherein the body's nervous system is weakened by an autoimmune reaction that attacks the myelin sheaths of neurons.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library